Back to results
US 2013/0096168 A1Published application
Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
AssigneeNovartis AG
InventorsYuki IWAKI, Toshio KAWANAMI, Gary Michael KSANDER, Muneto MOGI
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound of formula I; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R6, A1, A2, X1, s and m are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Claims12
1-19. (canceled)
The compound of Formula Ill:
- wherein
- X1 represent OH or O—C1-6-alkyl;
- A1 is a bond or CH2;
- R1 is methyl or ethyl;
- R5 and R4 are H;
- R3 is tetrazole;
- X2 is halo;
- for each occurrence, R2 is independently C1-6-alkoxy, hydroxy, halo, C1-6-alkyl, cyano or trifluoromethyl;
- and
- p is 0 or an integer from 1 to 4;
- R6 for each occurrence is independently halo, hydroxy, C1-7alkoxy, halo, C1-7alkyl or halo-C1-7akyl;
- and
- s is 0 or an integer from 1 to 4;
- or a pharmaceutically acceptable salt thereof.
11 more elements
Dependencies are inferred from the claim text.